VectorY is a startup based in the Netherlands, most recent round Series A, 3 tracked investors.
Based in the Netherlands, VectorY is a startup founded in 2018. Its most recent tracked round is Series A. Brouky records 3 investors associated with the company.
VectorY is a gene therapy company developing innovative gene therapies for neurodegenerative diseases. They utilize proprietary AAV-based vectorized antibody platforms to deliver therapeutic proteins to the central nervous system.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.